"Long-term use of GlaxoSmithKline's Avandia and Takeda's Actos doubles the risk of bone fractures in women with type 2 diabetes, according to a study released on Wednesday.Type 2 diabetes is fat person diabetes.
Scientists already knew the two thiazolidinedione (TZD) drugs for diabetes were associated with fractures, but the magnitude of the risk had not been evaluated.
'This study shows that these agents double the risk of fractures in women with type 2 diabetes, who are already at higher risk before taking the therapy,' said Sonal Singh of North Carolina's Wake Forest University School of Medicine."
Kudos, fatsos.
No comments:
Post a Comment